Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new 2019 efforts to improve the quality of compounded drugs - FDA Press Releases

FDA shares its 2019 compounding priorities as the agency works to improve the quality of compounded drugs

from Food and Drug Administration--Press Releases https://ift.tt/2TTsETe
via IFTTT